213 related articles for article (PubMed ID: 18561895)
21. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status.
Al-Ayyoubi S; Gali-Muhtasib H
Mol Carcinog; 2007 Mar; 46(3):176-86. PubMed ID: 17192871
[TBL] [Abstract][Full Text] [Related]
22. Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin.
Han Z; Wei W; Dunaway S; Darnowski JW; Calabresi P; Sedivy J; Hendrickson EA; Balan KV; Pantazis P; Wyche JH
J Biol Chem; 2002 May; 277(19):17154-60. PubMed ID: 11877436
[TBL] [Abstract][Full Text] [Related]
23. A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells.
Halaschek-Wiener J; Wacheck V; Schlagbauer-Wadl H; Wolff K; Kloog Y; Jansen B
Mol Med; 2000 Aug; 6(8):693-704. PubMed ID: 11055588
[TBL] [Abstract][Full Text] [Related]
24. Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells.
Premkumar DR; Jane EP; Pollack IF
Cancer Biol Ther; 2015; 16(2):233-43. PubMed ID: 25482928
[TBL] [Abstract][Full Text] [Related]
25. Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma Cells.
Klungsaeng S; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
Am J Chin Med; 2020; 48(6):1475-1489. PubMed ID: 32907364
[TBL] [Abstract][Full Text] [Related]
26. USP39 mediates p21-dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis.
Yuan J; Li X; Zhang G; Cheng W; Wang W; Lei Y; Ma Q; Song G
Mol Carcinog; 2021 Apr; 60(4):265-278. PubMed ID: 33634905
[TBL] [Abstract][Full Text] [Related]
27. KRAS and YAP1 converge to regulate EMT and tumor survival.
Shao DD; Xue W; Krall EB; Bhutkar A; Piccioni F; Wang X; Schinzel AC; Sood S; Rosenbluh J; Kim JW; Zwang Y; Roberts TM; Root DE; Jacks T; Hahn WC
Cell; 2014 Jul; 158(1):171-84. PubMed ID: 24954536
[TBL] [Abstract][Full Text] [Related]
28. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells.
Watson JL; Hill R; Yaffe PB; Greenshields A; Walsh M; Lee PW; Giacomantonio CA; Hoskin DW
Cancer Lett; 2010 Nov; 297(1):1-8. PubMed ID: 20472336
[TBL] [Abstract][Full Text] [Related]
29. Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives.
Brito H; Martins AC; Lavrado J; Mendes E; Francisco AP; Santos SA; Ohnmacht SA; Kim NS; Rodrigues CM; Moreira R; Neidle S; Borralho PM; Paulo A
PLoS One; 2015; 10(5):e0126891. PubMed ID: 26024321
[TBL] [Abstract][Full Text] [Related]
30. Potential of cucurbitacin as an anticancer drug.
Li Y; Li Y; Yao Y; Li H; Gao C; Sun C; Zhuang J
Biomed Pharmacother; 2023 Dec; 168():115707. PubMed ID: 37862969
[TBL] [Abstract][Full Text] [Related]
31. Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cells.
Halaschek-Wiener J; Wacheck V; Kloog Y; Jansen B
Cell Signal; 2004 Nov; 16(11):1319-27. PubMed ID: 15337531
[TBL] [Abstract][Full Text] [Related]
32. Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies.
Steckel M; Molina-Arcas M; Weigelt B; Marani M; Warne PH; Kuznetsov H; Kelly G; Saunders B; Howell M; Downward J; Hancock DC
Cell Res; 2012 Aug; 22(8):1227-45. PubMed ID: 22613949
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic Ras promotes butyrate-induced apoptosis through inhibition of gelsolin expression.
Klampfer L; Huang J; Sasazuki T; Shirasawa S; Augenlicht L
J Biol Chem; 2004 Aug; 279(35):36680-8. PubMed ID: 15213223
[TBL] [Abstract][Full Text] [Related]
34. HCT116 cells deficient in p21(Waf1) are hypersensitive to tyrosine kinase inhibitors and adriamycin through a mechanism unrelated to p21 and dependent on p53.
Ferrandiz N; Martin-Perez J; Blanco R; Donertas D; Weber A; Eilers M; Dotto P; Delgado MD; Leon J
DNA Repair (Amst); 2009 Mar; 8(3):390-9. PubMed ID: 19150257
[TBL] [Abstract][Full Text] [Related]
35. Octahedral Pt(IV) complex K101 induces apoptosis via ERK1/2 activation and the p53 pathway in human colon cancer cells.
Kwon YE; Kim KH
Anticancer Drugs; 2006 Jun; 17(5):553-8. PubMed ID: 16702812
[TBL] [Abstract][Full Text] [Related]
36. The Determination of Molecular and Toxicological Mechanisms of Cucurbitacin E in Model Organism
Tunçbilek A; Azarkan SY; Ercan F
Curr Comput Aided Drug Des; 2023; 19(2):81-93. PubMed ID: 36321227
[TBL] [Abstract][Full Text] [Related]
37. Anti-proliferative effect of 23,24-dihydrocucurbitacin F on human prostate cancer cells through induction of actin aggregation and cofilin-actin rod formation.
Ren S; Ouyang DY; Saltis M; Xu LH; Zha QB; Cai JY; He XH
Cancer Chemother Pharmacol; 2012 Sep; 70(3):415-24. PubMed ID: 22814677
[TBL] [Abstract][Full Text] [Related]
38. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
Mahyar-Roemer M; Roemer K
Oncogene; 2001 Jun; 20(26):3387-98. PubMed ID: 11423989
[TBL] [Abstract][Full Text] [Related]
39. Selenomethionine induces p53 mediated cell cycle arrest and apoptosis in human colon cancer cells.
Goel A; Fuerst F; Hotchkiss E; Boland CR
Cancer Biol Ther; 2006 May; 5(5):529-35. PubMed ID: 16627976
[TBL] [Abstract][Full Text] [Related]
40. p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells.
Perletti G; Marras E; Dondi D; Osti D; Congiu T; Ferrarese R; de Eguileor M; Tashjian AH
Int J Cancer; 2005 Jan; 113(1):42-53. PubMed ID: 15386430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]